A phase Ib study of a pooled synthetic long peptide mutant KRAS vaccine combined with balstilimab/botensilimab in metastatic pancreatic cancer and metastatic MMR-proficient colorectal cancer in the maintenance setting.

Authors: Kai-li Liang, Amanda Huff, Maureen Berg, Hao Wang, Julie Nauroth, Kyle Friedman, Amy Thomas, Madeline Figlewski, Dan Laheru, Elizabeth M. Jaffee, Neeha Zaidi, Nilofer Saba Azad

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2698

Source: Full article

---

Abstract

TPS2698